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Transient retinal ischemia results in a delayed cell death of the inner retinal layers. This study 
demonstrates that this ischemic cell death occurs, at least in part, through apoptosis. The general 
endonuclease inhibitor, aurintricarboxylic acid, protected rat retinal cells from ischemic cell 
damage when administered before the onset of ischemia and, more importantly, when administered 
6 hr after the insult. Thus, the demonstration that transient retinal ischemia results in cell damage 
as a result of apoptosis opens new therapeutic strategies aimed at lessening retinal damage as a 
result of this process. © 1997 Elsevier Science Ltd 
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INTRODUCTION 
Many similarities exist between cerebral and retinal 
ischemia, including the concept of delayed neuronal 
death (DND). In humans (subsequent to cardiac arrest) 
(Petito et al., 1987) and in animal models of transient 
cerebral ischemia (Pulsinelli et al., 1982), histologic 
damage appears to progress despite restoration of blood 
flow. This "maturation" phenomenon has been described 
in the retina as well (Szabo et al., 1991). DND after 
transient ischemia has been linked to several different 
pathophysiological processes including excess calcium 
influx (Takahashi et al., 1993), glutamate toxicity 
(Mosinger et al., 1991), and formation of free radicals 
(Szabo et al., 1991). This suggests that therapeutic 
strategies for limiting ischemic damage that focus on any 
one of these pathologic processes will have limited 
success. An alternative approach would be to intervene in 
common pathways of cell death that may be activated by 
each of these mechanisms. Recent studies both in vitro 
(Rosenbaum et al., 1994) and in vivo (Nitatori et al., 
1995; Linnik et al., 1993) suggest that DND after 
transient ischemia may, at least in part, be secondary to 
apoptosis. This study sought to determine whether cell 
death after retinal ischemia is apoptotic, and whether 
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drugs which have been shown to inhibit neuronal 
apoptosis in vitro (Batistatou & Greene, 1991) could 
prevent ischemic retinal neuronal death in vivo. 
METHODS 
Retinal ischemia 
Male Sprague-Dawley rats weighing 150-250 g were 
anesthetized with an intraperitoneal injection of ketamine 
(30mg/kg) and xylazine (2.5mg/kg). The anterior 
chamber of the right eye was cannulated with a 27-gauge 
needle attached to an infusion line of normal saline and to 
a manometer. The corneal puncture site was sealed with 
cyanoacrylate cement.  The intraocular pressure was 
raised to 150 mmHg for a duration of 60 rain. Through- 
out the ischemic period systemic blood pressure was 
monitored with catheterization f the tail artery. Retinal 
ischemia was confirmed by whitening of the iris and loss 
of the red reflex of the retina. After 60 min of ischemia, 
the needle was withdrawn and the intraocular pressure 
normalized. One drop of gentamicin ophthalmic solution 
and atropine 1% ophthalmic solution was applied 
topically to the right eye before and after cannulation 
of the anterior chamber. 
Light microscopy 
The right (experimental) and left (untouched control) 
globes were enucleated 1 week after ischemia and were 
fixed in Trump's fixative (Yoon & Marmor, 1989). The 
globes were sectioned in the vertical meridian and the 
inferior portion of the eye wall (retina, choroid and 
sclera) embedded in epoxy-resin. 1/~m-thick sections 
were stained with 1% toluidine blue. The retinal 
histoarchitecture was evaluated by light microscopy. 
The thickness of the retinal layers was measured as 
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FIGURE l. Histopathology of the rat retina in control (a) and ischemic (b) eyes. The control retina demonstrates a normal retinal 
histoarchitectural p ttern, while in the ischemic retina there is marked thinning and collapse of the inner etinal layers as well as 
disorganization f the cells in the outer nuclear layer (ONL). Toluidine blue, original magnification x80. (c) Histopathology of 
the rat retina prophylactically treated with ATA prior to ischemia. The normal retinal histoarchitectural p ttern is well 
preserved, however, there is some dema of the inner etinal layers as well as dropout of scattered cells in the inner nuclear layer 
and in the outer nuclear layer (ONL). Toluidine blue, original magnification x80. (d) Histopathology of the rat retina treated with 
ATA subsequent to ischemia. The retinal histoarchitecture is well preserved. There is mild inner etinal edema, dropout and 
pyknosis of scattered cells in the inner nuclear layer, as well as mild disorganization f the nuclei n the outer nuclear layer 
(ONL). Toluidine blue, original magnification x80. 
follows: (1) outer limiting membrane (OLM) to inner 
limiting membrane (ILM); (2) outer nuclear layer (ONL); 
(3) inner nuclear layer (INL)+outer plexiform layer 
(OPL); (4) INL; (5) inner plexiform layer (IPL) to ILM. 
Averages for these measurements taken in four adjacent 
areas within 1 mm of the optic nerve were calculated. 
Additionally, manual cell counts of the inner nuclear 
layer were performed over a length of 200 #m in the 
inferior peripapillary region. Selection of the same 
topographic region of the retina for all of these 
measurements is important in order to protect against 
possible regional anatomic variation. 
DNA fragmentation 
For detection of low molecular weight oligonucleotide 
fragments, oluble DNA was prepared (Rosenbaum et al., 
1994). Briefly, the retinas from two eyes were isolated by 
dissection for each time point, washed twice with ice cold 
PBS (pH 7.4), and lysis buffer was added (95 mM Tris 
(pH 7.4), 20 mM ethylenediaminetetraacetic acid 
(EDTA), and 0.5% Triton X-100. Cells were collected 
into this, gently agitated for 20 rain at 4°C, and then 
centrifuged for 2 min at top speed in a microfuge. The 
supernatants were extracted sequentially twice with Tris- 
buffered phenol (pH 8.0) and once with chloroform 
isoamyl alcohol (24:1 vol/vol). The nucleic acids were 
then precipitated by ethanol, resuspended in TE, and 
digested with RNAse (50 pg/ml). After spectrophoto- 
metric quantitation, the DNA was separated by agarose 
gel electrophoresis and transferred to a Gene Screen Plus 
membrane (NEN). Hybridization and washes were 
carried out according to the manufacturer's instructions. 
Radiolabeled probe was prepared using RNAse-digested 
genomic DNA by random priming. Membranes were 
exposed to film for 1-4 days with two intensifying 
screens. 
Transmission electron 
1/tm-thick sections of the retina stained with uranyl 
acetate and lead citrate were examined for the ultra- 
structural features of apoptosis. 
Drug administration 
Aurintricarboxylic acid (ATA) (Sigma) was injected 
intravitreally into the superotemporal quadrant of the 
right eye, 1 mm posterior to the limbus, with a 30-gauge 
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FIGURE 2. (a--c) Measurements (mean _+ SEM) of the thickness of retinal layers of non-ischemic eyes (control), of  untreated 
eyes (ischemia) and of eyes pretreated with ATA (ischemia + ATA). The thickness of the entire retina as measured fi:om the 
outer limiting membrane to the inner limiting membrane (a), of the inner nuclear layer (INL) (b), and of the inner retinal ayers 
as measured from the inner plexiform layer to the inner limiting membrane (c) were significantly thicker in the ischemic eyes 
pretreated with ATA than in the ischemic untreated eyes. (d) Manual cell counts of the INL in control eyes and 7 days after 
ischemia in ischemic untreated and ischemic pretreated ( ischemia+ATA) eyes. *Differs from control and from 
ischernic + ATA at P < 0.01. **Differs from control at P < 0.00l and from ischemia + ATA at P < 0.01 (n = 5 per ;group). 
needle. The drug was dissolved in 0.01 ml normal saline. 
The ischemic ontrol eyes received 0.01 ml of the vehicle 
(normal saline) intravitreally. One drop of gentamicin 
ophthalmic solution was applied topically before and 
after injection for infection prophylaxis. 
RESULTS 
Ischemia 
Ischemia produced by this technique restdted in the 
typical histopathologic features expected subsequent to
acute retinal ischemia (Foos, 1976). The globes were 
enucleated 7 days after ischemia for histopathologic 
study as it has previously been shown that pathologic 
changes in rat animal models of retinal ischemia are 
present 1 week after ischemia (Yoon & Marmot, 1989) 
and are morphometrically similar to those observed 14 
days after reperfusion (Zhang et al., 1995). 
In the ischemic, untreated eyes there was marked 
thinning of the inner retinal ayers (as measured from the 
inner nuclear layer to the inner limiting membrane, 
inclusive) as compared to control retinas [Fig. l(a, b)]. 
Specifically, there was a 37% reduction in the thickness 
of the ischemic retina (OLM-ILM) as compared to the 
untouched controls [Fig. 2(a)]. There was also extensive 
disorganization of the inner retinal histoarchitecture of 
the ischemic eyes with loss of the distinct boundaries of 
each of the layers, as well as collapse of the outer 
plexiform layer as compared to the control retinas [Fig. 
1 (a, b)]. The number of cells in the inner nuclear layer of 
the ischemic retinas was reduced by 45% [Fig. 2(d)]. The 
marked disorganization and atrophy of the innermost 
retinal layers precluded our ability to assess retinal 
ganglion cell density. The histoarchitecture of the outer 
nuclear layer showed isruption of the orderly, vertically 
oriented columnar arrangement of cells as well as 
cytologic irregularities [Fig. l(b)]. Scattered subretinal 
melanophages in the ischemic retinas suggested isrup- 
tion of the retinal pigment epithelium [Fig l(b)]. 
DNA fragmentation 
Endogenous endonuclease activation, resulting in the 
cleavage of chromatin into oligonucleosome-length DNA 
fragments is a characteristic biochemical marker for 
apoptosis (Batistatou & Greene, 1991). 
Retinal tissue was subjected to 60 min of' ischemia nd 
was examined after periods of 12 or 24 hr of reperfusion 
for evidence of internucleosomal DNA fra~gmentation. A 
DNA ladder pattern of degradation with characteristic 
fragments eparated in size by approximately 180-200 
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synchrony with progressive changes in nuclear morphol- 
ogy. The earliest signs of death were observed in normal 
size somata: moderate clumping of chromatin and the 
appearance of many membrane-bound cytoplasmic 
vacuoles. Full-sized somata with vacuolated cytoplasm 
were rare, suggesting that cell shrinkage and nuclear 
FIGURE 3. Evidence of retinal apoptosis by endonuclease digestion of 
DNA. Control (lane A) and ischemic retinas were dissected from adult 
rats and soluble low molecular weight DNA was isolated. Reperfusion 
following an ischemic episode (60 min) was allowed for 12 hr (lane B) 
or 24 hr (lane C). Bands corresponding to endonuclease digested DNA 
were seen at multiples of 180-200 bp, with a characteristic "laddering" 
pattern maximal at 12 hr. Pretreatment 24 hr before ischemia with 
ATA reduced the amount of laddering (lane D), suggesting decreased 
apoptosis. 
base pairs was apparent after 12 hr of reperfusion (lane B) 
and was still present after 24 hr of reperfusion (lane C) 
(Fig. 3). There was no evidence of DNA in the non- 
ischemic control (lane A, Fig. 3) since only low 
molecular weight soluble DNA, liberated subsequent to
cell death, is detectable by this technique. Although the 
presence of DNA ladder is not requisite for the 
demonstration of apoptosis, its presence is generally 
considered characteristic of the process. 
Transmission electron microscopy 
Ultrastructural analysis of the retina was performed 
after 12 hr of reperfusion to further differentiate between 
necrotic and apoptotic mechanisms. In this sample, many 
dying cells were noted in the inner nuclear and ganglion 
cell layers, while the outer nuclear layer was virtually 
spared. Most dying cells conformed to previous descrip- 
tions of apoptosis [Fig. 4(B)], with few examples of 
necrosis (Kessler et al., 1993). Rare necrotic cells had 
very electron dense cytoplasm and swollen mitochondria. 
FIGURE 4. Transmission electron microscopy, original magnifications 
×4160. (A) Cells in the INL of retina of a control (unoperated) eye 
showed no ultrastructural signs of apoptosis. (B) Apoptotic ell deaths 
in the INL after 12 hr of reperfusion following an ischemic episode. 
Cell 1 shows early signs of degeneration: small dense aggregates of 
chromatin throughout the nucleus, and a vacuolated cytoplasm. Cells 2 
and 3 demonstrate middle stages, with cell shrinkage due to loss of 
cytoplasm, and dense clumps of chromatin along the inner margin of 
the nuclear membrane. Cell 4 shows a very late stage in cell death, 
where the plasma membrane and nuclear membrane have broken 
down, leaving a cluster of small bits of dense chromatin behind. (C) 
INL of retina of an ischemic eye, prophylactically treated with ATA 
prior to ischemia, followed by 12 hr of reperfusion. No cell deaths were 
noted in the INL, although some cells showed moderate vacuolation of 
the cytoplasm (closed arrowheads). 
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FIGURE 5. (A-C) Measurements (mean _+ SEM) of the thickness of retinal ayers of non-ischemic eyes (control), of untreated 
eyes (ischemic), and of eyes treated subsequent to ischemia (post-ischemic ATA). The latter group of eyes received 4 pg ATA 
intravitreally 6 hr subsequent to the onset of a 60 min period of retinal ischemia. The entire retinal thickness (A) and the inner 
retinal layers (B, C) were significantly thicker in the eyes treated with ATA subsequent to ischemia than in the ischemic 
untreated eyes. (D) Manual cell counts of the INL in control eyes and 7 days after transient retinal ischemia (60 min duration) in 
untreated (ischemic) and post-ischemic treated (post-ischemic ATA) eyes (n = 6 per group). (A) *Differs from ischemic at 
P < 0.01. **Differs from control at P < 0.01. ***Differs from control at P < 0.001. (B) *Differs from ischemic at P < 0.01. 
**Differs from control at P < 0.00l. (C) *Differs from ischemic at P < 0.01. **Differs from control at P < 0.001. (D) ~Differs 
from control at P < 0.01. **Differs :from ischemic at P < 0.001. ***Differs from control at P < 0.001. 
condensation proceeded rapidly once apoptosis was 
triggered. Middle stages of death involved the progres- 
sive loss of cytoplasmic volume, apparently via mem- 
brane blebbing. Densely clumped chromatin became 
bound to the inner surface of the nuclear membrane. 
During middle stages, ribosomes became aggregated in
the cytoplasm, endoplasmic reticulum swelled, cytoplas- 
mic vacuoles declined in number, and mitochondria 
usually remained unswollen. In later stages, cytoplasm 
disappeared and nuclei became more shrunken and 
uniformly dense. Finally, the nuclear membrane broke 
down and chromatin was left behind in small dense 
clusters. Thus, retinal neurons dying after ischemia nd 
reperfusion displayed ultrastructural features character- 
istic of apoptosis. 
Protection with ATA 
ATA has been shown to inhibit apoptotic ell death 
induced by a variety of processes (Batistatou & Greene, 
1991; Ueda & Shaw, 1992). The ability of ATA to 
prevent apoptotic neuronal death after transient retinal 
ischemic injury was therefore xamined. 
In the first set of experiments, ATA was administered 
intravitreally 24 hr prior to the onset of 60 min of retinal 
ischemia to determine if this agent ('ould afford 
significant protection from ischemic injury. Prophylactic 
administration f ATA resulted in striking preservation 
of the normal retinal histoarchitectural p tte:m [Fig. 1 (c)], 
of the thicknesses of the inner retinal ayers [Fig. 2(b, c)] 
as well as the inner nuclear layer cell density [Fig. 2(d)]. 
Ultrastructurally, no cell deaths were noted within the 
INL of these retinas [Fig. 4(C)]. 
In a separate set of experiments, ATA was adminis- 
tered 6 hr subsequent to60 min of retinal ischemia. This 
resulted in relative preservation of the normal retinal 
histoarchitecture with some edematous c]~ange of the 
inner retinal ayers. There was only mild disturbance of 
the vertically oriented columns of nuclei in the outer 
nuclear layer as well as mild nuclear irregularities [Fig. 
1 (d)]. There was only a 17% reduction in the thickness of 
the retina (OLM-ILM) [Fig. 3(A)] and a 36% reduction 
in the thickness of the inner retina (IPL-ILM) [Fig. 5(C)] 
as compared to the untouched controls. The thickness 
of the inner nuclear layer was reduced by 8% [Fig. 5(B)] 
and the cell density in the inner nuclear layer was reduced 
by 15% [Fig. 5(D)] as compared to the untouched 
controls. 
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DISCUSSION 
ATA protected retinal cells from ischemic ell damage 
secondary to transient ischemia, not only when adminis- 
tered before the onset of ischemia, but also when 
administered 6 hr after the insult. In addition, because 
ATA inhibits apoptosis of cultured neurons, these results 
further support he hypothesis that the delayed cell death 
following transient retinal ischemia may result in 
apoptotic ell death of the inner retinal ayers. 
Calcium toxicity (Takahashi et al., 1993), excitatory 
toxicity (Mosinger et aL, 1991), and oxidative stress 
(Szabo et aL, 1991) have all been postulated to contribute 
to the pathogenesis ofdelayed neuronal death that occurs 
after transient cerebral and retinal ischemia. Each of 
these pathways may predispose cells to apoptosis. It 
therefore follows that apoptosis may play a role in DND 
as well. 
In further support of the relationship between ischemia 
and apoptosis, it has been shown that retinal ischemia 
results in increased intracellular free Ca 2÷, and retinal 
damage can be attenuated by Ca 2÷ blocker therapy 
administered prior to the insult (Takahashi et al., 1992). 
Increased intracellular Ca 2÷ can activate a number of 
cytosolic enzymes capable of damaging the cell (Franklin 
& Johnson, 1992). In addition, calcium activation of 
nuclear enzymes, including endonucleases, has been 
demonstrated (Lipton & Rosenberg, 1994). Activation of 
nuclear endonucleases results in DNA fragmentation a d 
chromatin condensation indicating that the increased 
intracellular Ca 2+ observed in apoptosis may play a role 
in cell death, perhaps by activating endonucleases. The 
Ca2++ chelator EGTA prevents apoptosis in NGF 
deprived neurons and, conversely, elevation of intracel- 
lular Ca 2÷ induces apoptosis in thymocytes (Martin et al., 
1992). 
Alternatively, mechanisms involving oxidant injury 
may be involved. Reactive oxygen species (ROS) are 
assuming a prominent role in retinal ischemia and free 
radical scavengers have been documented to ameliorate 
cell damage (Szabo et al., 1991). ROS play a significant 
role in apoptosis as well (Hockenbery et al., 1990). 
Oxidant injury leads to apoptosis in models of oxidant 
stress in dissociated neuronal culture and in spinal cord 
explants (Rothstein et al., 1994). The bcl-2 gene product 
may prevent apoptosis by its antioxidant properties 
(Hockenbery et al., 1990; Zhong et al., 1993). 
ATA is an endonuclease inhibitor, and some or all of 
its effects in inhibiting apoptosis may be related to this 
activity. ATA has also been reported to be an inhibitor of 
glutamate receptors and to have numerous other 
biological effects (Csernansky et al., 1994). However, 
since glutamate receptor antagonists do not offer the 
same remarkable degree of protection as ATA in retinal 
ischemia (Yoon & Marmor, 1989), the mechanism of 
ATA cannot be ascribed to this activity alone. Regardless 
of how ATA inhibits apoptosis, the findings of this study 
validate the concept hat inhibition of apoptosis may be 
valuable clinically. 
In conclusion, the results of these studies uggest that 
transient retinal ischemia results in apoptotic ell death. 
This is not to say that ischemia results in apoptotic ell 
death exclusively, but rather ischemia may trigger 
cytosolic or nuclear events that could restdt in necrosis 
as well as apoptosis. These data also demonstrate hat 
administration of ATA intravitreally 6 hr after the 
ischemic insult afforded significant protection. The 
ability to rescue even 6 hr after the ischemic event is of 
extreme clinical significance because it would allow 
those affected to receive therapy in a timely fashion. 
Most agents that have shown protection only do so when 
administered prior to ischemia. Furthermore, intravitreal 
injection of this agent is a practical and easy method of 
administering this therapy in the clinical setting. 
Inhibitors of apoptosis may thus offer ne, w therapeutic 
strategies aimed at lessening retinal damage in acute 
vascular occlusion as well as in other ophthalmologic 
disorders whose pathogenetic mechanism may involve 
ischemia, such as glaucoma, diabetic retinopathy and 
hypertensive vascular disease. However, before such 
therapy can be instituted, further studies are necessary to 
determine its efficacy in preserving the functional 
capacity of the retina since it is possible that retinal 
function may be impaired subsequent toischemia despite 
morphological preservation. Additionally, studies of any 
long-term untoward effects of ATA adrninistration are 
needed. 
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